RICHARD LOGAN: Open Payments
NPI 1043085871 · OAK PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,648 in 62 payments from 13 companies in 2025. Trend: 2023 $19 · 2024 $293 · 2025 $1,648
Food & beverage: $1,648
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $288 |
| Neurocrine BioSciences, Inc. | 11 | $253 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $207 |
| Alkermes, Inc. | 11 | $202 |
| Janssen Pharmaceuticals, Inc | 6 | $194 |
| Supernus Pharmaceuticals, Inc. | 2 | $148 |
| Otsuka America Pharmaceutical, Inc. | 5 | $120 |
| Almatica Pharma LLC | 3 | $78 |
| Lundbeck LLC | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $36 |
Products named: COBENFY, INGREZZA, CAPLYTA, REXULTI, Qelbree, ARISTADA, SPRAVATO, LOREEV XR.
Industry payments across IL — which companies pay providers there.
